The largest database of trusted experimental protocols

5 protocols using leu15 gastrin

1

Liver Tumor Organoid Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor organoid lines were generated from liver biopsy or resection tissue according to published protocols8 (link),9 (link). Briefly, tumor tissues were dissociated to small-cell clusters and seeded in domes of basement membrane extract type 2 (BME2, R&Dsystems, Cat. No. 3533-005-02). Polymerized BME2 domes were overlaid with expansion medium (EM): advanced DMEM/F-12 (Gibco, Cat. No. 12634010) supplemented with 1× B-27 (Gibco, Cat. No. 17504001), 1× N-2 (Gibco, Cat. No. 17502001), 10 mM Nicotinamide (Sigma, Cat. No. N0636), 1.25 mM N-Acetyl-L-cysteine (Sigma, Cat. No. A9165), 10 nM [Leu15]-Gastrin (Sigma, Cat. No. G9145), 10 μM Forskolin (Tocris, Cat. No. 1099), 5 μM A83-01 (Tocris, Cat. No. 2939), 50 ng/ml EGF (Peprotech, Cat. No. AF-100-15), 100 ng/ml FGF10 (Peprotech, Cat. No. 100-26), 25 ng/ml HGF (Peprotech, Cat. No. 100-39), 10% RSpo1-conditioned medium (v/v, homemade). Cultures were kept at 37 °C in a humidified 5% CO2 incubator. Organoids were passaged weekly at 1:4–1:6 split ratios using 0.25% Trypsin-EDTA (Gibco, Cat. No. 25200056). Frozen stocks were prepared at regular intervals. All organoid cultures were regularly tested for Mycoplasma contamination using the MycoAlert™ Mycoplasma detection kit (Lonza, Cat. No. LT07-118).
+ Open protocol
+ Expand
2

Establishment of Hepatocellular Carcinoma Organoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
The stable HCC organoid lines used in this study have been reported previously18 (link). Briefly, ultrasound-guided tumor biopsies were obtained from patients undergoing diagnostic liver biopsy at the University Hospital Basel. Written informed consent was obtained from all patients and the study was approved by the ethics committee of the northwestern part of Switzerland (Protocol Number EKNZ 2014-099). Tumor needle biopsy tissue was rapidly transferred to the lab, minced, and digested with 2.5 mg/mL collagenase IV (Sigma), 0.1 mg/mL DNase (Sigma) at 37 °C for 5 min. Digested biopsy/cell clusters were then seeded into reduced growth factor BME2 (Basement Membrane Extract, Type 2; Amsbio). After polymerization of BME2, expansion medium was added to the BME2 droplets. The composition of the medium is: advanced Dulbecco’s modified Eagle’s medium (DMEM)/F-12 (GIBCO) supplemented with 1:50 B-27 (GIBCO), 1:100 N-2 (GIBCO), 10 mM nicotinamide (Sigma), 1.25 mM N-acetyl-l-cysteine (Sigma), 10 nM [Leu15]-gastrin (Sigma), 10 mM forskolin (Tocris), 5 mM A83-01 (Tocris), 50 ng/mL EGF (PeproTech), 100 ng/mL FGF10 (PeproTech), 25 ng/mL HGF (PeproTech), and 10% RSpo1-conditioned medium (homemade). Tumor organoids were passaged by dissociation with 0.25% Trypsin-EDTA (GIBCO).
+ Open protocol
+ Expand
3

Colon Organoid Culture Optimization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Colonic glands were isolated, treated with EDTA, and then resuspended in 30–50 μL of Matrigel (BD Bioscience) and plated in 24-well plates. Wnt/R-spondin/Noggin (WRN) containing DMEM/F12 with HEPES (Sigma-Aldrich) containing 20% fetal bovine serum, 1% penicillin/streptomycin, and 50 ng/mL recombinant mouse epidermal growth factor (Life Technologies) was used for culturing ApcKO colon organoids. For the first 2–3 days after seeding, the media were also supplemented with 10 mmol/L ROCK inhibitor Y-27632 (Sigma Aldrich) and 10 mmol/L SB431542 (Sigma Aldrich), an inhibitor for the TGF-β type I receptor, to avoid anoikis. For passage, colon organoids were dispersed by trypsin-EDTA and transferred to fresh Matrigel. Passage was performed every 3–4 days with a 1:3–5 split ratio. For normal human colon organoid culture, the previous media were supplemented with antibiotics 100 μg/mL Primocin (Invivogen), 100 μg/mL Normocin (Invivogen), serum-free supplements 1× B27 (Thermo Fisher [Gibco]) and 1 × N2 (Thermo Fisher [Gibco]), chemical supplements 10 mmol/L nicotinamide (Sigma) and 500 mmol/L N-acetylcysteine (Sigma), hormone 50 mmol/L [Leu15]-Gastrin (Sigma), growth factor 100 μg/mL fibroblast growth factor 10 (recombinant human; Thermo Fisher), and 500 nmol/L A-83–01 (Sigma), an inhibitor of TGF-β receptors ALK4, 5, and 7.
+ Open protocol
+ Expand
4

Cryopreservation and Expansion of Human Cholangiocyte Organoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCCOs were passaged after dissociation with 0.25% Trypsin-EDTA (Gibco) for 5 minutes. Cells were seeded into reduced growth factor BME2 (Basement Membrane Extract Type 2; R&D Systems) mixed 1:1 with an expansion medium (EM). After polymerization of the BME2, an EM (based on Huch et al24 (link)) was added to the cells. The composition is advanced DMEM/F-12 (Gibco) supplemented with 1:50 B-27 (Gibco), 1:100 N-2 (Gibco), 10 mM nicotinamide (Sigma), 1.25 mM N-acetyl-l-cysteine (Sigma), 10 nM [Leu15]-gastrin (Sigma), 10 µM forskolin (Tocris), 5 µM A83-01 (Sigma), 50 ng/mL EGF (PeproTech), 100 ng/mL FGF10 (PeproTech), 25 ng/mL HGF (PeproTech), and 10% RSPO1-conditioned medium (homemade). Cryovials were prepared by resuspending dissociated organoids in a Recovery Cell Culture Freezing Medium (Gibco) before freezing. Expansion of HCCOs was exclusively performed under 20% O2 (normoxia).
+ Open protocol
+ Expand
5

Culturing Mouse and Human Colon Organoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Colonic glands were isolated, treated with EDTA, and then resuspended in 30 to 50 μl of Matrigel (BD Bioscience) and plated in 24-well plates. WRN containing DMEM/F12 with Hepes (Sigma-Aldrich) containing 20% FBS, 1% penicillin-streptomycin, and recombinant mouse epidermal growth factor (50 ng/ml; Life Technologies) was used for culturing ApcKO colon organoids. For the first 2 to 3 days after seeding, the medium was also supplemented with 10 mM ROCK inhibitor Y-27632 (Sigma-Aldrich) and 10 mM SB431542 (Sigma-Aldrich), an inhibitor for the transforming growth factor–β (TGF-β) type I receptor to avoid anoikis. For passage, colon organoids were dispersed by trypsin-EDTA and transferred to fresh Matrigel. Passage was performed every 3 to 4 days with a 1:3 to 1:5 split ratio. For human colon organoid culture, the previous medium was supplemented with antibiotics Primocin (100 μg/ml; InvivoGen) and Normocin (100 μg/ml; InvivoGen), serum-free supplements 1× B27 [Thermo Fisher Scientific (Gibco)] and 1× N2 [Thermo Fisher Scientific (Gibco)], chemical supplements 10 mM nicotinamide (Sigma-Aldrich) and 500 mM N-acetyl cysteine (Sigma-Aldrich), hormone 50 mM [Leu15]-Gastrin (Sigma-Aldrich), growth factor FGF10 (100 μg/ml; recombinant human; Thermo Fisher Scientific), and 500 nM A-83-01 (Sigma-Aldrich), which is an inhibitor of the TGF-β receptors ALK4, ALK5, and ALK7.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!